This inventor holds 1 USPTO granted patent. Top assignee: Kansas State University Research Foundation. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Yasuaki Hiromasa: Innovator in Amphipathic Peptide Technology
Introduction
Yasuaki Hiromasa is a notable inventor based in Manhattan, Kansas. He has made significant contributions to the field of peptide technology, particularly through his innovative work on branched amphipathic oligo-peptides. His research focuses on the self-assembly of these peptides into vesicles, which has potential applications in various scientific fields.
Latest Patents
Hiromasa holds a patent for "Branched amphipathic oligo-peptides that self-assemble into vesicles." This invention provides a novel approach to creating branched amphipathic peptides and the vesicles formed from them. The peptides consist of a polar/positively charged C-terminal segment, a branch point, and two hydrophobic N-terminal segments. When mixed, these peptides self-assemble into small spheres defined by a membrane made of an interlocking peptide network bilayer, which has a liquid-receiving interior space. This unique structure allows the peptide assembly to maintain stability at reduced concentrations, where traditional lipid vesicles would typically break down.
Career Highlights
Yasuaki Hiromasa is affiliated with the Kansas State University Research Foundation, where he continues to advance his research in peptide technology. His work has garnered attention for its innovative approach and potential applications in various scientific domains.
Collaborations
Hiromasa has collaborated with esteemed colleagues such as John M. Tomich and Takeo Iwamoto. These collaborations have contributed to the advancement of his research and the development of new technologies in the field.
Conclusion
Yasuaki Hiromasa is a pioneering inventor whose work on branched amphipathic oligo-peptides has opened new avenues in peptide technology. His contributions are significant in the scientific community, and his ongoing research promises to yield further innovations in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
